Skip to main content

The importance of neurorehabilitation to the outcome of neuromodulation in spasticity

  • Chapter

Part of the book series: Acta Neurochirurgica Supplements ((NEUROCHIRURGICA,volume 97/1))

Summary

The neuromodulation specialist who is involved in the management of spasticity should not be interested only in the technical aspects of the implantation of a device. It is important that (s)he has a sound understanding of all aspects of this serious disability in order to determine appropriately whether an ablative or a neuromodulatory intervention (intrathecal baclofen administration, spinal cord stimulation, peripheral nerve stimulation) is best for the patient. It is also important that s(he) is able to collaborate effectively with the physiatrists, othopaedic surgeons, neurologists, physiotherapists, neuropsychologists, and care counselors. In this article, we review our approach to the neurorehabilitation of patients with spasticity due to multiple sclerosis, spinal cord injury, cerebrovascular disease or head injury and, on the basis of our experience, we highlight the importance of the integrated management that combines both rehabilitation and neuromodulation methods in order to ensure the maximum benefits for the patients.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Azouvi P, Mane M, Thiebaut JB, Denys P, Remy-Neris O, Bussel B (1996) Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow up. Arch Phys Med Rehabil 77: 35–39

    Article  PubMed  CAS  Google Scholar 

  2. Bach-y-Rita P (1981) Central nervous system lesions: sprouting and unmasking in rehabilitation. Arch Phys Med Rehabil 62: 413–417

    PubMed  Google Scholar 

  3. Bach-y-Rita P (1981) Brain plasticity as a basis of the development of rehabilitation procedures for hemiplegia. Scand J Rehabil Med 13: 73–83

    PubMed  CAS  Google Scholar 

  4. Barnes MP, Kent RM, Semlyen JK, McMullen KM (2003) Spasticity in multiple sclerosis. Neurorehabil Neural Repair 17: 66–70

    Article  PubMed  CAS  Google Scholar 

  5. Becker R, Alberti O, Bauer BL (1997) Continuous intrathecal baclofen infusion in severe spasticity after traumatic or hypoxic brain Injury. J Neurol 224: 160–166

    Article  Google Scholar 

  6. Ben Smail D, Peskine A, Roche N, Mailhan L, Thiebaut I, Bussel B (2006) Intrathecal baclofen for treatment of spasticity of multiple sclerosis patients. Mult Scler 12: 101–103

    Article  PubMed  CAS  Google Scholar 

  7. Bobath K, Bobath B (1984) The neuro-developmental treatment. In: Scrutton D (ed) Management of motor disorders of children with cerebral palsy. Lippencott JB, Philadelphia, pp 6–18

    Google Scholar 

  8. Bohannon RW, Smith MB (1987) Inter rater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 67: 206–207

    PubMed  CAS  Google Scholar 

  9. Boviatsis EJ, Kouyialis AT, Korfias S, Sakas DE (2005) Functional outcome of intrathecal baclofen administration for severe spasticity. Clin Neurol Neurosurg 107: 289–295

    Article  PubMed  Google Scholar 

  10. Brunnstrom S (1966) Motor testing procedures in hemiplegia: based on sequential recovery stages. Phys Ther 46: 357–375

    PubMed  CAS  Google Scholar 

  11. Corry IS (1997) Botulinum toxin A in the hemiplegic upper limb:a double-blind trial. Dev Med Child Neurol 39: 185–193

    Article  PubMed  CAS  Google Scholar 

  12. Dario A, Di Stefano MG, Grossi A, Casagrande F, Bono G (2002) Long-term intrathecal baclofen infusion in supraspinal spasticity of adulthood. Acta Neurol Scand 105: 83–87

    Article  PubMed  CAS  Google Scholar 

  13. Dietz V, Quintern J, Berger W (1981) Electrophysiological studies of gait in spasticity and rigidity. Evidence that altered mechanical properties of muscle contribute to hypertonia. Brain 104: 431–449

    Article  PubMed  CAS  Google Scholar 

  14. Dietz V, Wirz M, Curt A, Colombo G (1998) Locomotor pattern in paraplegic patients: training effects and recovery of spinal cord function. Spinal Cord 36: 380–390

    Article  PubMed  CAS  Google Scholar 

  15. Ditunno JF, Little JW, Tessler A, Burns AS (2004) Spinal shock revisited: a four-phase model. Spinal Cord 42: 383–395

    Article  PubMed  CAS  Google Scholar 

  16. Dykstra DD, Sidi AA (1990) Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study. Arch Phys Med Rehabil 71: 24–26

    PubMed  CAS  Google Scholar 

  17. Dromerick AW (2002) Clinical features of spasticity and principles of treatment. In: Gelber DA, Douglas RJ (eds) Evaluation and management of spasticity. Humana Press, Totawa, NJ, pp 13–26

    Google Scholar 

  18. Fehlings D, Rang M, Glazier J, Steele C (2000) An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy. J Pediatr 137: 331–337

    Article  PubMed  CAS  Google Scholar 

  19. Francis HP, Wade DT, Turner-Stokes L, Kingswell RS, Dott CS, Coxon EA (2004) Does reducing spasticity translate into functional benefit? An exploratory meta-analysis. J Neurol Neurosurg Psychiatry 75: 1547–1551

    Article  PubMed  CAS  Google Scholar 

  20. Francisco GE, Boake C, Vaughn A (2002) Botulinum toxin treatment of upper extremity spasticity secondary to acquired brain injury: a randomized trial comparing two commonly used dilution techniques. Am J Phys Med Rehabil 8: 355–363

    Article  Google Scholar 

  21. Francisco GE, Hu MM, Boake C, Ivanhoe CB (2005) Efficacy of early use of intrathecal baclofen therapy for treating spastic hypertonia due to acquired brain injury. Brain Inj 19: 359–364

    PubMed  CAS  Google Scholar 

  22. Francois B, Vacher P, Roustan J, Salle JY, Vidal J, Moreau JJ, Vignon P (2001) Intrathecal baclofen after traumatic brain injury: early treatment using a new technique to prevent spasticity. J Trauma 50: 158–161

    PubMed  CAS  Google Scholar 

  23. Gracies JM, Nance P, Elovic E, McGuire J, Simpson DM (1997) Traditional pharmacological treatments for spacticity part II: general and regional treatments. Muscle Nerve Suppl 6: S92–S120

    Article  PubMed  CAS  Google Scholar 

  24. Gracies JM, Fitzpatrick R, Wilson L, Burke D, Gandevia SC (1997) Lycra garments designed for patients with upper limb spasticity: mechanical effects in normal subjects. Arch Phys Med Rehabil 78: 1066–1071

    Article  PubMed  CAS  Google Scholar 

  25. Gracies JM, Nance P, Elovic E, McGuire J, Simpson DM (1997) Traditional pharmacological treatments for spacticity part I: local treatments. Muscle Nerve Suppl 6: S1–S92

    Google Scholar 

  26. Hallenborg SC (1990) Positioning in the practical management of spasticity. In: Glenn MB, Whyte J (eds) Children and adults. Lea and Febinger, Philadelphia, pp 97–117

    Google Scholar 

  27. Hesse S, Werner C, von Frankenberg S, Bardeleben A (2003) Treadmill training with partial body weight support after stroke. Phys Med Rehabil Clin N Am 14Suppl 1: S111–S123

    PubMed  Google Scholar 

  28. Kabus C, Hecht M, Japp G, Jost WH, Pohlau D, Stuckrad-Barre S, Winterholler M (2006) Botulinum toxin in patients with multiple sclerosis. J Neurol 253Suppl 1: i26–i28

    Article  PubMed  CAS  Google Scholar 

  29. Kagaya H, Yamada S, Nagasawa T, Iashihara Y, Kodama H, Endoh H (1996) Split posterior tibial tendon transfer for various deformity of the hind-foot. Clin Orthop Rel Res 323: 254–260

    Article  Google Scholar 

  30. Keenan MAE, McDaid PJ (2002) Orthopedic interventions for the management of limb deformities in upper motoneuron syndromes. In: Gelber DA, Jeffrey DR (eds) Clinical evaluation and management of spasticity. Humana Press, Totowa, NJ, pp 197–255

    Google Scholar 

  31. Ko HY, Ditunno JF, Graziani V, Little JW (1999) The pattern of reflex recovery during spinal shock. Spinal Cord 37: 402–409

    Article  PubMed  CAS  Google Scholar 

  32. Kraft GH, Fitts SS, Hammond MC (1992) Techniques to improve function of the hand and arm in chronic hemiplegia. Arch Phys Med Rehabil 73: 220–227

    PubMed  CAS  Google Scholar 

  33. Kunkel A, Kopp B, Muller G, Villringer K, Villringer A, Taub E, Flor H (1999) Constraint-induced movement therapy. A powerful new technique to induce motor recovery in chronic stroke patients. Arch Phys Med Rehabil 80: 624–628

    Article  PubMed  CAS  Google Scholar 

  34. Lieber RL, Jan Fride N (2002) Spasticity causes a fundamental rearrangement of muscle-joint interaction. Muscle Nerve 25: 265–270

    Article  PubMed  Google Scholar 

  35. Mayer NH (1997) Clinicophysiologic concepts of spasticity and motor dysfunction in adults with an upper motoneuron lesion. Muscle Nerve Suppl 6: S1–S13

    Article  PubMed  CAS  Google Scholar 

  36. Meythaler JM (2002) Pharmacology update: intrathecal baclofen for spastic hypertonia in brain injury. J Head Trauma Rehabil 12: 87–90

    Article  Google Scholar 

  37. Nancy B, Jennifer R, Olfat M, Monica H, Josh K, Amy S, Molly T, Gary A (2003) Effectiveness of sensory and motor rehabilitation of the upper limb following the principles of neuroplasticity: patients stable poststroke. Neurorehabil Neural Repair 17: 176–191

    Article  Google Scholar 

  38. Nudo RJ, Wise BM, SiFuentes F, Milliken GW (1996) Neural substrates for the effects of rehabilitation training on motor recovery after ischemic infarct. Science 272: 1791–1794

    Article  PubMed  CAS  Google Scholar 

  39. Petropoulou K, Rapidi A-C, Noussias V, Berbatiotou L (2001) Study of the effectiveness of botulinum toxin type A in hemiplegic arm spasticity. Neurorehab Neural Repair 15: 323 (abstract)

    Google Scholar 

  40. Pierson SH (2002) Physical and occupational approaches. In: Gelber DA, Jeffery DR (eds) Clinical evaluation and management of spasticity. Humana Press, Totawa, NJ, pp 47–66

    Google Scholar 

  41. Seeberger LC, O’Brien CF (2002) Botulinum toxins. In: Gelber DA, Jeffery DR (eds) Clinical evaluation and management of spasticity. Humana Press, Totawa, NJ, pp 173–186

    Google Scholar 

  42. Simpson DM (1997) Clinical trials of botulinum toxin in the treatment of spasticity. Muscle Nerve Suppl 6: S169–S175

    Article  PubMed  CAS  Google Scholar 

  43. Smeulders MJC, Kreulen M, Huijing JHPA, van der Horst CM (2005) Spastic muscle properties are affected by length changes of adjacent structures. Muscle Nerve 32: 208–215

    Article  PubMed  Google Scholar 

  44. Snow BJ, Tsui JK, Bhatt MH, Varelas M, Hashimoto SA, Calne DB (1990) Treatment of spasticity with botulinum toxin: a double-blind study. Ann Neurol 28: 512–515

    Article  PubMed  CAS  Google Scholar 

  45. Stokic DS, Yablon SA, Hayes A (2005) Comparison of clinical and neurophysiologic responses to intrathecal baclofen bolus administration in moderate-to-severe spasticity after acquired brain injury. Arch Phys Med Rehabil 86: 1801–1806

    Article  PubMed  Google Scholar 

  46. Taub E, Burgio L, Miller NE, Cook EW III, Groomes T, DeLuca S, Crago J (1994) An operant approach to overcoming learned nonuse after CNS damage in monkeys and man: the role of shaping. J Exp Anal Behav 61: 281–293

    Article  PubMed  CAS  Google Scholar 

  47. Tilton AH (2003) Approach to the rehabilitation of spasticity and neuromuscular disorders in children. Neurol Clin 21: 853–881

    Article  PubMed  Google Scholar 

  48. Tizard JP (1980) Cerebral palsies: treatment and prevention. The Croonian lecture 1978. J R Coll Physicians 14: 72–77

    CAS  Google Scholar 

  49. Zafonte R, Lombard L, Elovic E (2004) Antispasticity medications: uses and limitations of enteral therapy. Am J Phys Med Rehabil 83: S50–S58

    Article  PubMed  Google Scholar 

  50. Zahavi A, Geertzen JH, Middel B, Staal M, Rietman JS (2004) Long term effect (more than five years) of intrathecal baclofen on impairment, disability, and quality of life in patients with severe spasticity of spinal origin. J Neurol Neurosurg Psychiatry 75: 1553–1557

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Konstantina B. Petropoulou .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag

About this chapter

Cite this chapter

Petropoulou, K.B., Panourias, I.G., Rapidi, C.A., Sakas, D.E. (2007). The importance of neurorehabilitation to the outcome of neuromodulation in spasticity. In: Sakas, D.E., Simpson, B.A., Krames, E.S. (eds) Operative Neuromodulation. Acta Neurochirurgica Supplements, vol 97/1. Springer, Vienna. https://doi.org/10.1007/978-3-211-33079-1_33

Download citation

  • DOI: https://doi.org/10.1007/978-3-211-33079-1_33

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-33078-4

  • Online ISBN: 978-3-211-33079-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics